These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20382061)

  • 1. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B.
    Sayan M; Sentürk O; Akhan SÇ; Hülagü S; Cekmen MB
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e136-41. PubMed ID: 20382061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral drug-associated potential vaccine-escape hepatitis B virus mutants in Turkish patients with chronic hepatitis B.
    Sayan M; Akhan SC
    Int J Infect Dis; 2011 Oct; 15(10):e722-6. PubMed ID: 21784687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.
    Sayan M; Akhan SC; Meric M
    J Viral Hepat; 2010 Jan; 17(1):23-7. PubMed ID: 19566788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
    Sayan M; Hülagü S; Akhan SC; Sentürk O; Meriç M; Cekmen M
    Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug resistance, genotype, and serotype of hepatitis B virus in nucleos(t)ide analogue naive patients with chronic hepatitis B].
    Li XG; Xu J; Liu BM; Yang JX; Yan L; Li T; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):92-5. PubMed ID: 20196945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
    Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
    J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy.
    Yeh CT
    Antivir Ther; 2010; 15(3 Pt B):471-5. PubMed ID: 20516567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
    Reijnders JG; Perquin MJ; Zhang N; Hansen BE; Janssen HL
    Gastroenterology; 2010 Aug; 139(2):491-8. PubMed ID: 20381492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers.
    Roque-Afonso AM; Férey MP; Ly TD; Graube A; Costa-Faria L; Samuel D; Dussaix E
    Antivir Ther; 2007; 12(8):1255-63. PubMed ID: 18240865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.
    Liu BM; Li T; Xu J; Li XG; Dong JP; Yan P; Yang JX; Yan L; Gao ZY; Li WP; Sun XW; Wang YH; Jiao XJ; Hou CS; Zhuang H
    Antiviral Res; 2010 Mar; 85(3):512-9. PubMed ID: 20034521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus resistance to nucleos(t)ide analogues.
    Zoulim F; Locarnini S
    Gastroenterology; 2009 Nov; 137(5):1593-608.e1-2. PubMed ID: 19737565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.
    Li XG; Liu BM; Xu J; Liu XE; Ding H; Li T
    J Med Virol; 2012 Feb; 84(2):207-16. PubMed ID: 22170539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary pattern of full hepatitis B virus genome during sequential nucleos(t)ide analog therapy.
    Tang YZ; Liu L; Pan MM; Wang YM; Deng GH
    Antiviral Res; 2011 Jun; 90(3):116-25. PubMed ID: 21440005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia.
    Lazarevic I; Cupic M; Delic D; Svirtlih NS; Simonovic J; Jovanovic T
    J Med Virol; 2010 Jul; 82(7):1160-7. PubMed ID: 20513079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region.
    Natsuizaka M; Hige S; Ono Y; Ogawa K; Nakanishi M; Chuma M; Yoshida S; Asaka M
    J Viral Hepat; 2005 Mar; 12(2):154-9. PubMed ID: 15720530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutation patterns in the RT region of hepatitis B virus P gene in patients treated with nucleoside/nucleotide analogs].
    DENG J; ZHANG DH; YU DM; CHEN L; ZHANG XX
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):342-5. PubMed ID: 19497198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping.
    Ohishi W; Shirakawa H; Kawakami Y; Kimura S; Kamiyasu M; Tazuma S; Nakanishi T; Chayama K
    J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection.
    Bozdayi G; Türkyilmaz AR; Idilman R; Karatayli E; Rota S; Yurdaydin C; Bozdayi AM
    J Med Virol; 2005 Aug; 76(4):476-81. PubMed ID: 15977237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.
    Ogura Y; Kurosaki M; Asahina Y; Enomoto N; Marumo F; Sato C
    J Infect Dis; 1999 Nov; 180(5):1444-51. PubMed ID: 10515802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.